These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28968921)

  • 21. Reply to "Anti-cytokeratin CAM5.2 recognized CK8 mainly, but not CK18: comment on 'Early assessment of axillary response with 18F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla. Ann Surg Oncol. 2013;20(7):2227-35'".
    Koolen BB; Wesseling J
    Ann Surg Oncol; 2014 Feb; 21(2):700. PubMed ID: 24052316
    [No Abstract]   [Full Text] [Related]  

  • 22. Reply to C. Fontanella et al.
    Azim HA; de Azambuja E; Agbor-Tarh D; Bradbury I
    J Clin Oncol; 2014 Oct; 32(30):3459. PubMed ID: 25225439
    [No Abstract]   [Full Text] [Related]  

  • 23. Neoadjuvant breast cancer therapy and drug development.
    Cortazar P; Kluetz PG
    Clin Adv Hematol Oncol; 2015 Nov; 13(11):755-61. PubMed ID: 27058702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival benefit from response-guided approach: a direct effect of more effective cytotoxic regimens or an indirect effect of chemotherapy-induced amenorrhea? Reply to K.-D. Yu et al.
    von Minckwitz G; Loibl S
    J Clin Oncol; 2014 Apr; 32(12):1283-4. PubMed ID: 24638006
    [No Abstract]   [Full Text] [Related]  

  • 25. Neoadjuvant chemotherapy in breast cancer: more than just downsizing.
    Derks MGM; van de Velde CJH
    Lancet Oncol; 2018 Jan; 19(1):2-3. PubMed ID: 29242042
    [No Abstract]   [Full Text] [Related]  

  • 26. Preoperative roentgen therapy of cancer of the breast: preliminary communication.
    BORGSTROM S; LINDGREN M
    Acta radiol; 1962 Feb; 58():9-16. PubMed ID: 13871334
    [No Abstract]   [Full Text] [Related]  

  • 27. Is there still a role for neoadjuvant therapy in breast cancer?
    Shannon C; Smith I
    Crit Rev Oncol Hematol; 2003 Jan; 45(1):77-90. PubMed ID: 12482573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant systemic therapy in breast cancer: Challenges and uncertainties.
    Van de Wiel M; Dockx Y; Van den Wyngaert T; Stroobants S; Tjalma WAA; Huizing MT
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():144-156. PubMed ID: 28039758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of neoadjuvant therapy in breast carcinoma].
    Winzer KJ
    Chirurg; 2000 Dec; 71(12):1458-65. PubMed ID: 11195064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vacuum-Assisted Biopsy to Diagnose a Pathological Complete Response in Breast Cancer Patients After Neoadjuvant Systemic Therapy.
    Heil J; Richter H; Golatta M; Sinn HP
    Ann Surg; 2018 Dec; 268(6):e60-e61. PubMed ID: 29064903
    [No Abstract]   [Full Text] [Related]  

  • 31. [Neoadjuvant therapy in breast cancer].
    Ena G
    Rev Med Brux; 2011 Sep; 32(4):243-6. PubMed ID: 22034752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clarifying the role of neoadjuvant therapy in breast cancer.
    Zelnak A
    Oncology (Williston Park); 2010 Feb; 24(2):149. PubMed ID: 20361465
    [No Abstract]   [Full Text] [Related]  

  • 33. ASO Author Reflections: Role of Contrast-Enhanced Spectral Mammography in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy.
    Hilal T; Patel BK
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):652-653. PubMed ID: 30324476
    [No Abstract]   [Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy for operable breast cancer: individualizing locoregional and systemic therapy.
    Bear HD
    Surg Oncol Clin N Am; 2010 Jul; 19(3):607-26. PubMed ID: 20620930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using neoadjuvant therapy for breast cancer in clinical practice: when and how?
    Tripathy D
    Breast Cancer Res Treat; 2012 Apr; 132(3):775-7. PubMed ID: 22438051
    [No Abstract]   [Full Text] [Related]  

  • 36. [Systemic neoadjuvant therapy of luminal breast cancer in 2016].
    Cottu PH
    Bull Cancer; 2017 Jan; 104(1):69-78. PubMed ID: 27817858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast reconstruction after neoadjuvant radio chemotherapy: review and personal technique IDEAL concept REV-EJMR-D-15-00268.
    Nestle-Krämling C; Bölke E; Budach W; Andree C
    Eur J Med Res; 2016 Jun; 21(1):24. PubMed ID: 27287332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How Much Information Do We Really Need After Neoadjuvant Therapy for Breast Cancer?
    Loibl S; Denkert C
    J Clin Oncol; 2017 Apr; 35(10):1029-1030. PubMed ID: 28135142
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of neoadjuvant chemotherapy on the overall treatment strategy in operable breast cancer].
    Zuo WS; Zheng MZ; Han C
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):952-957. PubMed ID: 29262515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant chemotherapy for early breast cancer.
    Krug D; Loibl S
    Lancet Oncol; 2018 Mar; 19(3):e129. PubMed ID: 29508754
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.